“The cross-contamination incident is unacceptable,” he stated, “period.”
About 60 million further doses have been discovered to be contaminated in June.
Fuad El-Hibri was born on March 2, 1958, in Hildesheim, Germany, the son of Elizabeth (Trunk) El-Hibri, a homemaker, and Ibrahim El-Hibri, an engineer and entrepreneur. He grew up in Lebanon and Germany and graduated from Stanford University in 1980 with a diploma in economics. He obtained a grasp’s diploma in private and non-private administration from the Yale School of Management in 1982.
He is survived by his spouse, Nancy (Grunenwald) El-Hibri; his mom; his brother, Samir; his sister, Yasmin El-Hibri Gibellini; his daughters, Faiza and Yusra El-Hibri; his son, Karim; and three grandchildren.
Mr. El-Hibri started his profession working for Citicorp in Saudi Arabia and later labored for the consulting agency Booz Allen Hamilton in Indonesia. After returning to the United States, he began a enterprise that helped nationwide telecom corporations improve their networks in Russia, Venezuela and El Salvador.
In the Nineteen Nineties he suggested the Saudi Arabian authorities on its efforts to purchase thousands and thousands of doses of an anthrax vaccine. That expertise seeded the concept for what grew to become Emergent BioSolutions.
He co-founded the corporate, initially known as BioPort, in 1998. He and his companions, together with William J. Crowe, a former admiral, quickly received a bid to purchase a disused authorities laboratory in Lansing, Mich., and improve it to provide anthrax vaccines for the U.S. navy.
The firm modified its title to Emergent BioSolutions in 2004. It went public in 2006.